Checchi Capital Advisers LLC Takes Position in Centene Corp (NYSE:CNC)
Checchi Capital Advisers LLC bought a new stake in Centene Corp (NYSE:CNC) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 5,087 shares of the company’s stock, valued at approximately $302,000.
Other institutional investors have also recently bought and sold shares of the company. Integrated Advisors Network LLC acquired a new position in shares of Centene in the fourth quarter valued at approximately $344,000. Bessemer Group Inc. grew its position in Centene by 251.8% during the fourth quarter. Bessemer Group Inc. now owns 1,101 shares of the company’s stock worth $69,000 after buying an additional 788 shares in the last quarter. Raymond James Trust N.A. acquired a new stake in Centene during the fourth quarter worth approximately $232,000. Steward Partners Investment Advisory LLC grew its position in Centene by 10.8% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 3,468 shares of the company’s stock worth $218,000 after buying an additional 339 shares in the last quarter. Finally, Huntington National Bank grew its position in Centene by 185.1% during the fourth quarter. Huntington National Bank now owns 1,032 shares of the company’s stock worth $65,000 after buying an additional 670 shares in the last quarter. 74.92% of the stock is currently owned by institutional investors.
A number of brokerages recently issued reports on CNC. Zacks Investment Research downgraded Centene from a “buy” rating to a “hold” rating and set a $72.00 price target on the stock. in a research report on Thursday, April 16th. Goldman Sachs Group began coverage on Centene in a research report on Friday, February 7th. They set a “buy” rating and a $80.00 price target on the stock. Morgan Stanley increased their price target on Centene from $85.00 to $89.00 and gave the stock an “overweight” rating in a research report on Monday, April 13th. Credit Suisse Group reissued a “hold” rating and set a $72.50 price target on shares of Centene in a research report on Wednesday, April 29th. Finally, Bank of America restated a “buy” rating and set a $82.00 target price on shares of Centene in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Centene currently has a consensus rating of “Buy” and an average price target of $82.78.
Centene (NYSE:CNC) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $0.86 EPS for the quarter, missing the Zacks’ consensus estimate of $0.99 by ($0.13). Centene had a net margin of 1.03% and a return on equity of 11.47%. The firm had revenue of $26.03 billion during the quarter, compared to the consensus estimate of $23.96 billion. During the same quarter in the previous year, the company posted $1.39 earnings per share. The firm’s revenue was up 41.1% on a year-over-year basis. As a group, equities analysts forecast that Centene Corp will post 4.71 EPS for the current year.
In related news, EVP Kenneth A. Burdick sold 35,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $67.09, for a total transaction of $2,348,150.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Tommy G. Thompson sold 1,500 shares of the firm’s stock in a transaction on Monday, April 6th. The stock was sold at an average price of $58.00, for a total value of $87,000.00. The disclosure for this sale can be found here. Insiders sold a total of 93,686 shares of company stock valued at $6,180,113 over the last quarter. 1.90% of the stock is owned by corporate insiders.
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.
Read More: Retained Earnings
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.